KQ · Healthcare

Kangstem Biotech Co. Ltd (217730)

Biotechnology

Kangstem Biotech Co. Ltd (217730) is listed on KQ in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 217730

P/E ratio

25.00

Kangstem Biotech Co. Ltd (217730) — FAQ

What is 217730's P/E ratio?

The price-to-earnings (P/E) ratio for Kangstem Biotech Co. Ltd (217730) is 25.00 (data as of 2026-05-24).

Does Kangstem Biotech Co. Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Kangstem Biotech Co. Ltd (217730). Check the MyAverix Finance app for the latest dividend data.

What sector is Kangstem Biotech Co. Ltd in?

Kangstem Biotech Co. Ltd (217730) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 217730 listed on?

217730 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)